Characteristics of the sample
| Interviewed (n=42) | All MBCT-TS participants (n=212) | |
| Demographic characteristics | ||
| Female (%) | 31 (74) | 151 (71) |
| White (%) | 42 (100) | 210 (99) |
| Age (in years) | ||
| M (SD) | 51.88 (10.51) | 50 (12) |
| Range | 25–72 | 22–78 |
| Psychiatric characteristics | ||
| Previous episodes | ||
| <6 episodes | 26 (62) | 120 (57) |
| ≥6 episodes | 16 (38) | 92 (43) |
| Comorbid mental health diagnoses | ||
| 1 or more (%) | 15 (36) | 75 (35) |
| Treatment preference at baseline | ||
| MBCT-TS preference (%) | 34 (81) | 150 (71) |
| ADM preference (%) | 1 (2) | 12 (6) |
| No preference (%) | 7 (17) | 50 (24) |
| Treatment outcome | ||
| Relapse | ||
| N (%) that relapsed during the follow-up phase | 23 (55) | 94 (44) |
| Antidepressant usage during the follow-up phase | ||
| Stopped and stayed stopped (%) | 13 (31) | 67 (32) |
| Stopped and resumed (%) | 9 (21) | 57 (27) |
| Reduced but never stopped (%) | 9 (21) | 29 (14) |
| Never stopped or reduced (%) | 11 (26) | 23 (11) |
| Residual depression symptoms | ||
| BDI score at baseline, M (SD) | 15.90 (11.35) | 13.8 (12.4) |
| BDI score at 24-month follow-up, M (SD) | 12.39 (12.25) | 11.6 (10.9) |
ADM, antidepressant medication; BDI, Beck Depression Inventory; MBCT-TS, mindfulness-based cognitive therapy with support to taper and discontinue ADMs.